Exo
PrivateLast Round
Series D
Jun 11, 2025
Total Funding Raised
$383.89M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Exo operates in Healthcare & Life Sciences and is based in Santa Clara, California. Its latest recorded funding round was a Series D round in June 2025.
Exo is a medical technology company that develops a handheld ultrasound device and AI-powered diagnostic and workflow software platform designed to enhance medical imaging and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exo Comparables
Compare Exo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EchoNous | 92% | |
| Clarius Mobile Health | 89% | |
| Butterfly Network | 86% |
For institutional investors. Book with your work email.
Exo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 11, 2025 | ||||
| Debt | Jul 29, 2024 | ||||
| Series C | Jul 29, 2021 | ||||
| Series B Extension | Aug 20, 2020 | ||||
| Series B | Aug 5, 2019 | ||||
Series A | Oct 2, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Exo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rising Tide Fund | Series B Extension, Series C, Seed, Series B |
| Boldstart Ventures | Series B Extension, Series C |
| RA Capital Management | Series C |
| Sony Ventures Corporation | Seed, Series B |
| Magnetar Capital | Seed, Series B, Series B Extension |
| Longevity Vision Fund | Series B Extension, Series B, Series C, Seed |
| Creative Ventures | Series B Extension, Series C, Seed, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 46% MoM.
- Mar 19, 2026
Sponsoring refreshment break at MEDTECH IMPACT SYMPOSIUM.
For institutional investors. Book with your work email.
Exo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Exo's valuation, stock price, and market status.
Is Exo a public or private company?
Exo is a private company.
What is the current stock price of Exo?
Exo is a private company, so its shares have no public market price. Caplight tracks Exo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exo worth (valuation)?
Valuation information for Exo is not publicly available.
Can I buy Exo stock?
Exo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exo's last funding round?
Exo's most recent funding round was Series D on June 11, 2025.
Who are the main investors in Exo?
Key investors in Exo include RA Capital Management, Magnetar Capital, Action Potential Venture Capital, Reimagined Ventures, Intel Capital.
Will Exo IPO soon?
No public IPO plans have been announced for Exo.
How can I track Exo secondary market activity?
Caplight tracks bids, offers, and trades in Exo's shares on secondary markets.